David Silberman serves as Executive at ORAMED PHARMACEUTICALS INC., where they oversee executive responsibilities. Since joining the company, David Silberman has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 4, 2024 involved receiving (via award) 136,500 shares valued at $0.
David Silberman currently holds 366,500 shares of ORAMED PHARMACEUTICALS INC. (ORMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Silberman has been a net neutral trader of ORMP stock. They have purchased $0 and sold $0 worth of shares.
David Silberman's most recent insider trade was on Jan 4, 2024, when they sold 136,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 17, 2023 | ORMP | $0 | Award | 97,500 | $N/A | Discretionary |
| Jul 28, 2022 | ORMP | $0 | Award | 39,000 | $N/A | Discretionary |
| Jan 3, 2022 | ORMP | $0 | Award | 19,000 | $N/A | Discretionary |
| Sep 1, 2021 | ORMP | $0 | Award | 50,000 | $N/A | Discretionary |